Lloyd B Mulenga
Overview
Explore the profile of Lloyd B Mulenga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
809
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tembo T, Heilmann E, Kabamba B, Fwoloshi S, Kalenga K, Chilambe F, et al.
BMC Public Health
. 2025 Feb;
25(1):813.
PMID: 40021963
Background: In Zambia, the true extent of SARS-CoV-2 infections is unknown because initial surveillance focused on patients with symptoms or severe disease. Antenatal sentinel surveillance had not been used to...
2.
Sikombe K, Mody A, Goss C, Simbeza S, Beres L, Pry J, et al.
Lancet HIV
. 2024 Dec;
12(1):e26-e39.
PMID: 39647496
Background: Recipients of health services value not only convenience but also respectful, kind, and helpful providers. To date, research to improve person-centred HIV treatment has focused on making services easier...
3.
Sharma A, Mwamba C, Clair-Sullivan N, Chihota B, Pry J, Bolton-Moore C, et al.
Int J Public Health
. 2024 May;
69:1606607.
PMID: 38711786
Objectives: We sought to understand the social construction of aging in a clinic-based population, with and without HIV, to address gaps in care for older individuals living with HIV in...
4.
Heilmann E, Tembo T, Fwoloshi S, Kabamba B, Chilambe F, Kalenga K, et al.
PLOS Glob Public Health
. 2024 Apr;
4(4):e0003073.
PMID: 38568905
SARS-CoV-2 serosurveys help estimate the extent of transmission and guide the allocation of COVID-19 vaccines. We measured SARS-CoV-2 seroprevalence among women attending ANC clinics to assess exposure trends over time...
5.
Sheppard R, Watson O, Pieciak R, Lungu J, Kwenda G, Moyo C, et al.
Nat Commun
. 2024 Mar;
15(1):2213.
PMID: 38472189
No abstract available.
6.
Mulenga L, Hines J, Stafford K, Dzekedzeke K, Sivile S, Lindsay B, et al.
AIDS
. 2024 Jan;
38(6):895-905.
PMID: 38227572
Background: The Zambian government has implemented a public health response to control the HIV epidemic in the country. Zambia conducted a population-based HIV impact assessment (ZAMPHIA) survey in 2021 to...
7.
Mweso O, Simwanza J, Malambo W, Banda D, Fwoloshi S, Sinyange N, et al.
BMJ Open
. 2023 Dec;
13(12):e072144.
PMID: 38072491
Objectives: The study aim was to evaluate vaccine effectiveness (VE) of COVID-19 vaccines in preventing symptomatic COVID-19 among healthcare workers (HCWs) in Zambia. We sought to answer the question, 'What...
8.
Muula G, Bosomprah S, Sinkala E, Nsokolo B, Musonda T, Hamusonde K, et al.
AIDS
. 2023 Jul;
37(13):2015-2020.
PMID: 37467044
Background: To inform novel therapies, a more nuanced understanding of HIV's impact on hepatitis B virus (HBV) natural history is needed, particularly in high burden countries. Methods: In Lusaka, Zambia,...
9.
Hines J, Prieto J, Itoh M, Fwoloshi S, Zyambo K, Sivile S, et al.
PLOS Glob Public Health
. 2023 Jul;
3(7):e0001686.
PMID: 37428721
Hypertension is a major risk factor for cardiovascular disease, which is a common cause of death in Zambia. Data on hypertension prevalence in Zambia are scarce and limited to specific...
10.
Sheppard R, Watson O, Pieciak R, Lungu J, Kwenda G, Moyo C, et al.
Nat Commun
. 2023 Jun;
14(1):3840.
PMID: 37380650
Reported COVID-19 cases and associated mortality remain low in many sub-Saharan countries relative to global averages, but true impact is difficult to estimate given limitations around surveillance and mortality registration....